1676 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Recruiting Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Intervention: Drug: Infusion Tranexamic acid or placebo.
2 Recruiting Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
3 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
4 Terminated The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Not yet recruiting A Pilot Feasibility And Safety Multicenter Trial Of Administering Weight FiXET Study
Condition: Venous Thromboembolism
Intervention: Drug: Enoxaparin
7 Recruiting The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
Condition: Migraine
Interventions: Drug: Cilostazol;   Drug: Sumatriptan;   Drug: Placebo
8 Recruiting Real-Life Evidence on Stroke Prevention in SPAF
Condition: Atrial Fibrillation (Prevention of Stroke)
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Vitamin K antagonists
9 Active, not recruiting PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
Conditions: Brain Ischemia;   Intracranial Hemorrhages
Interventions: Drug: cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: Placebo of aspirin;   Device: Intima-medial thickness
10 Active, not recruiting Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting
Condition: Stable Coronary Artery Disease With Coronary Artery Bypass Grafting
Intervention: Drug: Acetylsalicylic acid
11 Not yet recruiting Lacunar Intervention Trial 1 (LACI-1)
Conditions: Cerebral Small Vessel Diseases;   Cognitive Impairment;   Stroke
Interventions: Drug: isosorbide mononitrate;   Drug: cilostazol
12 Not yet recruiting Optimized Heparin Regimen in Vascular Surgery
Condition: Peripheral Revascularisation
Interventions: Procedure: ACT;   Procedure: TEG;   Procedure: Ankle-brachial index;   Procedure: Toe-brachial index;   Drug: Heparin
13 Active, not recruiting Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol
Condition: Chronic Renal Insufficiency
Intervention: Drug: Alteplase
14 Active, not recruiting Dose-effect Relationship of Rt-PA on ICH Evacuation
Condition: Hypertensive Intracerebral Hemorrhage
Interventions: Device: YL-1 type of intracranial hematoma puncture needle;   Drug: rt-PA
15 Not yet recruiting Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI
Conditions: Myocardial Ischemia;   Coronary Artery Disease;   Endothelial Dysfunction
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
16 Not yet recruiting Adjuvant Aspirin for Colon Cancer
Condition: Colon Cancer
Interventions: Drug: Aspirin;   Drug: Placebo
17 Recruiting Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
Conditions: Acute Coronary Syndrome;   Chronic Kidney Disease;   End-Stage Renal Disease
Interventions: Drug: Clopidogrel first;   Drug: Ticagrelor first
18 Completed The Blood Saving Effect of Tranexamic Acid in Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis
Condition: Osteoarthritis, Knee
Interventions: Drug: Tranexamic Acid 5%,5ml/amp (intraoperative);   Drug: Tranexamic Acid 5%,5ml/amp (3 hours after operation);   Drug: 0.9% Normal Saline  (intraoperative);   Drug: 0.9% Normal Saline (3 hours after operation);   Drug: rivaroxaban (10mg)
19 Recruiting Verapamil vs Heparin in Transradial Procedures
Condition: Heart Disease, Ischemic
Interventions: Drug: Heparin;   Drug: Verapamil
20 Not yet recruiting Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty
Condition: Osteoarthritis, Knee
Interventions: Drug: Tranexamic Acid 5%,5ml/amp;   Drug: rivaroxaban (10mg);   Drug: 0.9% Normal Saline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years